Further to understand the effect of low dose of DC on FasL-induced cell death in other cancer cells we performed similar experiments using cancer cell lines such as MDA-MB-231 (human breast adenocarcinoma cells), LNCap (human prostate adenocarcinoma cells), U-87 MG (human glioblastoma cells), and TXM-1 (human melanoma cells). This evidence concerns the gene FASLG and breast adenocarcinoma.